GlassScriptPhysician profile
Rajapriya Manickam
NPI 1285938431
$1,695.51
in general payments reported to CMS, 2019-2025
16 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.68 · 2023: $150 · 2024: $932 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $402.04 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $238.86 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $234.66 | 2024-2025 | Breztri, Fasenra, Airsupra |
| Mylan Specialty L.P. | $156.34 | 2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $150.00 | 2023 | Opsumit, Uptravi |
| United Therapeutics Corporation | $147.82 | 2024 | Tyvaso |
| Viatris Specialty LLC | $74.88 | 2025 | Yupelri |
| Insmed, INC. | $70.10 | 2024-2025 | Arikayce, Brinsupri |
| Amgen INC. | $43.06 | 2024 | |
| Merck Sharp & Dohme LLC | $39.55 | 2019-2024 | Keytruda |
| Regeneron Healthcare Solutions, INC. | $35.00 | 2024 | Dupixent |
| Harmony Biosciences LLC | $33.06 | 2024-2025 | |
| Abiomed | $23.84 | 2025 | |
| Verona Pharma, INC. | $16.32 | 2025 | Ohtuvayre |
| Masimo Corporation | $16.25 | 2024 | Sedline |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13.73 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajapriya Manickam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.